The aim of this prospective cohort study was to evaluate the effectiveness of the neonatal hip instability screening programme.
Developmental dysplasia of the hip (DDH) is a spectrum ranging from mild dysplasia to irreducible dislocation. 1 In England, the Newborn Infant Physical Examination (NIPE) Committee is responsible for screening guidelines. These consist of universal screening for instability of the hip within the first 72 hours postnatally, a clinical assessment of the hip by a general practitioner or health care professional at six weeks 2 and between four and six weeks a sonographic assessment of 'at-risk' newborns (born by breech presentation or with a family history of DDH).
The Barlow 3 and Ortolani 4 manoeuvres are the internationally accepted techniques used to identify neonatal instability of the hip. Despite the high specificity of both tests, the sensitivity of this screening has been reported to be 60%. 5 We have previously suggested that the quality of the screening had remained reasonably static for between ten and 15 years. 6, 7 In Sweden, Düppe and Danielsson 8 reported deterioration in the results of their screening programme, which was attributed to an increasing number of practitioners undertaking the screening manoeuvres. Anecdotally, it was also felt that there had been a deterioration in the quality of referrals to our specialist screening clinic.
The aim of this study is to assess the positive predictive value (PPV) of the initial screening examination of the hip, as defined by a positive Barlow or Ortolani manoeuvre, a clunk, or instability of the hip, by non-expert compared with an expert in screening, either finding a positive provocation test or Graf Type IV ultrasound scan, at approximately two weeks. 8 Previous authors have investigated the association of certain clinical signs with pathological DDH, including asymmetrical skin creases, limited abduction of the hip, and clicky hips.
9-11 These were not investigated in this study.
Patients and Methods
A prospective longitudinal observational study was undertaken at the, Royal Blackburn Teaching Hospital, between 1 January 2012 and 31 December 2015, in which there currently are slightly over 7000 live births per year, with a population of 530 000 in five districts. Since 1992, all cases of neonatal instability referred to the 'one-stop' DDH screening clinic have been clinically assessed and the hips have been imaged sonographically by the senior author (RWP). The information is prospectively recorded in a database. All cases of neonatal instability identified in the district are referred directly to this clinic by the Paediatric department East Lancashire Hospitals NHS trust or by midwives using a proforma. The newborn examination was undertaken by different health professionals, including newly qualified doctors (foundation doctors, doctors not in training), midwives, and advanced nurse practitioners. All had received training in examination of the newborn hip.
Inclusion criteria were a positive provocative test (Barlow and/or Ortolani manoeuvre), newborns referred with a positive 'clunk' on the Ortolani manoeuvre, and hips referred as positive for 'instability' (Fig. 1) .
Exclusion criteria included referrals for reasons other than possible neonatal instability of the hip such as those with at-risk factors, clicky hips, asymmetrical skin creases, limitation of abduction (bilaterally and unilaterally), and primary neurological or syndromic hip pathology. The diagnosis of DDH does not include neurological or syndromic causes, as these cases are secondary to a primary pathology. 12 Those not referred through the screening programme were deemed 'late' presentations and were excluded from the primary analysis of neonatal instability, although 'late' presentation cases of irreducible dislocation requiring surgery were recorded in order to calculate the sensitivity of the study.
In the 'one-stop' clinic, the hips were clinically assessed using the Barlow and Ortolani manoeuvres. Sonography of the hip was classified according to the modified Graf and Harcke classification (Table I) . [13] [14] [15] The outcome measures for this study were an unstable hip (a positive provocative test in clinic (Barlow or Ortolani manoeuvre or a Graf Type IV hip on sonography). It is accepted 
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in some quarters that a positive Graf Type IV scan may overdiagnose the condition when compared with positive clinical manoeuvres and may be a flawed outcome measure. 6 The sensitivity, specificity, and PPV were calculated for both the clinical and the sonographic assessments. In the sonographic group, an assumption was made that all clinically unstable hips which were referred would be expected to have, 'on the balance of probabilities', a Graf Type IV sonographic image. Without this assumption, the sonographic PPV could not be calculated. The birth rates for the districts covered by the East Lancashire Hospital NHS Trust were obtained from the Office for National Statistics.
A separate prospective spreadsheet was maintained for the newborns with irreducible dislocation, subluxation, and those with dysplasia requiring surgery including closed or open reduction and femoral or pelvic osteotomy. For the purposes of statistical analysis, a false negative result was an irreducible hip dislocation that presented 'late' after the screening period (outcome measure). Data were collected prospectively for at least 18 months after the end of the study in order to identify all newborns with an irreducible dislocation born within the fouryear study period.
A separate card index system was maintained prospectively to record all newborns diagnosed with sonographic abnormalities of the hip and/or Pavlik harness treatment 16 within the fouryear period of the study. This was a cross-checking system, separate to the primary database, maintained in order to identify and separate early from late diagnosed pathological cases.
Results
Between 1 January 2012 and 31 December 2015, 124 newborns were referred through the clinic with clinical evidence of instability of the hip: 100 with positive Barlow or Ortolani manoeuvres, 15 being unstable and nine clunks. There were 28 241 live births during this time.
The mean age at the time of assessment in the clinic was 16.1 days (95% confidence interval (CI) 14.0 to 18.2) in those who did not fail to attend their first appointment. These newborns were clinically assessed by the treating expert within four weeks of referral, within the NIPE guidelines. 2 Ten failed to attend the initial appointment and attended at a later date. The mean age at the time of assessment of these was 73.5 days (95% CI 56 to 91) and all had a normal clinical examination; sonographically, there were nine Graf Type I hips and one Graf Type II hip. All these abnormalities resolved without treatment.
On clinical assessment in the clinic, only five newborns, during the five years, had a positive provocative test. On sonographic assessment, 92 (74.1%) had a Graf Type I hip and a clinically normal hip.. These were discharged from the clinic. A total of 18 newborns presented initially with a Graf Type II hip and a normal hip clinically. Of the 18 Graf Type II hips, 12 resolved to normal Graf Type I hips spontaneously and six progressed to Type IV hips. A total of 14 Graf Type IV hips were diagnosed at the initial appointment with a total of 20 Type IV hips, including the six Type II hips that progressed to Type IV. Graf Type IV hips were treated with a Pavlik harness and 13 resolved; seven progressed and required subsequent surgery, with one closed reduction and six open reductions.
From 2012 to 2015, the rate of surgical intervention for irreducible hip dislocation and dysplasia in DDH was 1.1 per 1000 live births, compared with 0.62 per 1000 between 1997 and 2006. 6 The rate of surgery for irreducible dislocation increased to 0.96 per 1000, compared with 0.51 per 1000, during these periods. 6 Compared with the previous 15 years, the mean yearly number of referrals of instability increased from 13.4 to 31 (3.18 per 1000 live births increased to 4.4 per 1000 live births).
The PPV for Barlow/Ortolani positive newborns in the clinic was 4.0% (5/124). If referrals for 'instability' are excluded, and clunks and Barlow/Ortolani positive newborns are included, the PPV would still be only 5.0% (5/100). The PPV for sonographic assessment (the proportion of newborns referred with instability that were found to have a Graf Type IV hip on imaging) was 16.1% (20/124). The sensitivity of clinical assessment was 18.5% and of sonographic assessment was 47.6%. The specificity of clinical and sonographic assessment was 99.6%. The results are summarized in Tables  II and III . 
Discussion
Screening for the early detection of pathological DDH is a controversial issue, [17] [18] [19] for which there is no international consensus. 2, [20] [21] [22] Evidence is lacking to establish whether the NIPE screening programme has resulted in a reduction in late presenting dislocations in newborns with pathological DDH in England. 6, [23] [24] [25] [26] In the United Kingdom, despite a screening programme instituted in 1969, more than 60% of irreducible dislocations present late, often after the age of one year. 23 The overall rate of surgery for irreducible dislocation prior to selective sonographic screening in the United Kingdom was between 0.5 and 0.8 per 1000 live births. [24] [25] [26] However, Düppe and Danielsson 8 in Sweden and Myers et al 27 in New Zealand have shown a significant reduction in the rate of surgery for pathological DDH when a small group of well-trained, experienced examiners undertake the screening. A recent study from Australia recorded a concerning increase in the rate of irreducible dislocation. 28 In the United Kingdom, concern has been expressed about those who are currently responsible for undertaking the neonatal examination, who have varying degrees of training and experience. Recently, there has been a switch to stand-alone 'birthing centres', so that fewer babies are born in traditional hospital maternity units. It is not clear whether these changes have affected the effectiveness of the screening programme. 29 The natural history of resolution of neonatal hip instability has been well documented. Gardiner and Dunn 30 and Barlow 3 have reported that 71% of clinically unstable hips stabilize within two weeks and 88% stabilize by the first postnatal month without treatment. This may be a limitation to the objective nature of this study. However, as most of the hips in this study were assessed in the clinic close to two weeks postnatally, it would be expected that the clinical PPV would be between 20% and 30%, and that the sensitivity would be between 60% and 70%, based on previous studies. [5] [6] [7] We previously reported that the PPV and sensitivities for neonatal screening remained reasonably static over ten to 15 years (Table III) . 6, 7 The PPV in the current programme has fallen to 4.0%, compared with between 24% and 28% in previous studies. 6, 7 The PPV of sonographic Graf Type IV imaging has fallen to 16.1%, compared with between 49% and 68% in previous studies. 6, 7 Although the referral criteria of instability and the pathways in the previous two studies are the same, unidentified subtle differences and confounding factors in the collection of data could make direct comparison with this study less robust than expected. The clinical and sonographic examinations were undertaken by the same examiner (RWP), increasing the likelihood of unintentional bias, although this was unavoidable in this study as the clinic was consultant-based. The senior author (RWP), however, has over 20 years of experience of sonographic imaging of the hip and the quality and interpretation of his ultrasound scans have been independently validated as accurate at a national level (NIPE committee, a sub-group of the National Screening Committee). 2 Neonatal hip screening in the United Kingdom appears to have fragmented, with many stakeholders. Guidance in England is the responsibility of Public Health England. 31 Local health commissioning is the responsibility of the Clinical Commissioning Groups (CCG) 31 and the neonatal examination and screening of the hip is the responsibility of the paediatric department. In the community ('birthing centres'), midwives and nurses undertake the screening. Due to the low incidence of true clinical instability (Barlow/Ortolani positive), many undertaking this screening will have had little exposure to true instability of the hip with positive provocative manoeuvres. It is of concern that this study identified an apparent increase in the rate of surgery for irreducible dislocation of 0.96 per 1000 live births over a four-year period, compared with 0.51 per 1000 live births in the same institution in a ten-year period. 6 An additional possible reason for the increase in referrals and of false positives may be the fear of litigation.
There is continuing controversy about whether universal or selective sonographic hip screening is cost-effective. [12] [13] [14] [15] [16] [17] Woodacre et al 32 calculated that the cost of closed or open reduction procedures varied between £4 352 and £7 052, compared with approximately £41 for an ultrasound examination of the hip, and £156 for combined clinical and sonographic assessment by a consultant orthopaedic surgeon. 9 If universal ultrasound scanning is undertaken in all newborns by the radiological department alone, the cost in our service would be approximately £290 000 per year.
The cost of successful litigation for delayed diagnosis, later requiring surgery, ranges from £120 000 to £488 000 in out of court settlements. 33, 34 However, the early detection of pathological DDH does not prevent all surgery in these newborns, as some do not respond to treatment in a Pavlik harness. 7, 16 In conclusion, these results mirror the Swedish experience. 8 There appears to be a paradox of increasing referrals of neonatal instability of the hip combined with a decreasing PPV and an -Individuals undertaking neonatal hip screening require adequate training. -The large number of examiners of different backgrounds and experience undertaking neonatal hip screening for instability may be associated with an increase in false positive and false negative referrals. -It is important to limit hip screening for DDH to a small group of trained and experienced individuals, for maximum effectiveness, if the resources allow.
-A national audit on DDH screening should be considered.
